Adult stem cell therapy and heart failure, 2000 to 2016: a systematic review

PK Nguyen, JW Rhee, JC Wu - JAMA cardiology, 2016 - jamanetwork.com
Importance Stem cell therapy is a promising treatment strategy for patients with heart failure,
which accounts for more than 10% of deaths in the United States annually. Despite more …

Doxorubicin targets multiple players: a new view of an old problem

D Cappetta, F Rossi, E Piegari, F Quaini… - Pharmacological …, 2018 - Elsevier
Anthracycline cardiotoxicity remains a serious problem in paediatric and adult cancer
survivors, and the advancement of cardio-oncology is a necessary step for an effective care …

[HTML][HTML] V Diretriz da Sociedade Brasileira de Cardiologia sobre tratamento do infarto agudo do miocárdio com supradesnível do segmento ST

LS Piegas, A Timerman, GS Feitosa… - Arquivos brasileiros de …, 2015 - SciELO Brasil
Material de distribuição exclusiva à classe médica. Os Arquivos Brasileiros de Cardiologia
não se responsabilizam pelo acesso indevido a seu conteúdo e que contrarie a …

Global position paper on cardiovascular regenerative medicine

F Fernández-Avilés, R Sanz-Ruiz… - European heart …, 2017 - academic.oup.com
Based on the increasingly understood regenerative capacity of the human heart and
vascular system, 1 cardiovascular regenerative medicine (CRM) encompasses all potential …

Concise review: optimized strategies for stem cell-based therapy in myocardial repair: clinical translatability and potential limitation

R Wu, X Hu, J Wang - Stem Cells, 2018 - academic.oup.com
Ischemic heart diseases (IHDs) remain major public health problems with high rates of
morbidity and mortality worldwide. Despite significant advances, current therapeutic …

[HTML][HTML] Comparing the effect of bone marrow mono-nuclear cells with mesenchymal stem cells after acute myocardial infarction on improvement of left ventricular …

A Hosseinpour, F Kheshti, A Kazemi, A Attar - Stem Cell Research & …, 2022 - Springer
Background The effect of transplantation of bone-marrow mononuclear cells (BM-MNCs)
and mesenchymal stem cells (MSCs) on ejection fraction (LVEF) has been studied in …

Functionally improved mesenchymal stem cells to better treat myocardial infarction

Z Chen, L Chen, C Zeng, WE Wang - Stem cells international, 2018 - Wiley Online Library
Myocardial infarction (MI) is one of the leading causes of death worldwide. Mesenchymal
stem cell (MSC) transplantation is considered a promising approach and has made …

[HTML][HTML] Doxorubicin cardiotoxicity and target cells: a broader perspective

A De Angelis, K Urbanek, D Cappetta, E Piegari… - Cardio-Oncology, 2016 - Springer
The cardiotoxicity of doxorubicin is becoming an interdisciplinary point of interest given a
growing population of cancer survivors. The complex and not completely understood …

Cell therapy for heart disease after 15 years: unmet expectations

P Nigro, B Bassetti, L Cavallotti, V Catto… - Pharmacological …, 2018 - Elsevier
Over the past two decades cardiac cell therapy (CCT) has emerged as a promising new
strategy to cure heart diseases at high unmet need. Thousands of patients have entered …

Effect of cardiosphere-derived cells on segmental myocardial function after myocardial infarction: ALLSTAR randomised clinical trial

MR Ostovaneh, RR Makkar, B Ambale-Venkatesh… - Open …, 2021 - openheart.bmj.com
Background Most cell therapy trials failed to show an improvement in global left ventricular
(LV) function measures after myocardial infarction (MI). Myocardial segments are …